Cost-effectiveness of a reactive oral cholera immunization campaign using Shanchol™ in Malawi

Artificial Intelligence – An International Journal
Volume 292 March 2021
https://www.sciencedirect.com/journal/artificial-intelligence/vol/292/suppl/C

 


BMC Cost Effectiveness and Resource Allocation
http://resource-allocation.biomedcentral.com/
(Accessed 13 Mar 2021)
Cost-effectiveness of a reactive oral cholera immunization campaign using Shanchol™ in Malawi
Oral cholera vaccines (OCV) have been recommended as additional measures for the prevention of cholera. However, little is known about the cost-effectiveness of OCV use in sub-Saharan Africa, particularly in reactive outbreak contexts. This study aimed to investigate the cost-effectiveness of the use of OCV Shanchol in response to a cholera outbreak in the Lake Chilwa area, Malawi…Relative to the Malawi gross domestic product per capita, the reactive OCV campaign represented a cost-effective intervention, particularly when considering indirect vaccine effects. Results will need to be assessed in other settings, e.g., during campaigns implemented directly by the Ministry of Health rather than by international partners.
Authors: Patrick G. Ilboudo, Martin A. Mengel, Bradford D. Gessner, Bagrey Ngwira, Philippe Cavailler and Jean-Bernard Le Gargasson
Content type: Research
10 March 2021